Based on the Pfizer Inc. stock forecast from 0 analysts, the average analyst target price for Pfizer Inc. is not available over the next 12 months. Pfizer Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Pfizer Inc. is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Pfizer Inc.’s stock price was USD 26.60. Pfizer Inc.’s stock price has changed by -2.56% over the past week, +3.91% over the past month and -7.64% over the last year.
No recent analyst target price found for Pfizer Inc.
No recent average analyst rating found for Pfizer Inc.
Company Overview Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Read Less
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and w...Read More
Frequently Asked Questions About Pfizer Inc. (0Q1N:LSE) Stock
Stock Target Advisor's fundamental analysis for Pfizer Inc.'s stock is Slightly Bearish.
0Q1N:LSE stock's dividend yield is 6.50%.
Our analysis grades 0Q1N:LSE stock's dividend yield at A+. This means that 0Q1N:LSE stock's dividend yield is above 100% of the stocks in the Drug Manufacturers - General sector in the LSE exchange.
Based on this 0Q1N:LSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 0Q1N:LSE's stock to indicate what its average analyst target is.
0Q1N:LSE stock's Price/Earning ratio is 0.68.
Our analysis grades 0Q1N:LSE stock's Price / Earning ratio at F. This means that 0Q1N:LSE stock's Price/Earning ratio is above 50% of the stocks in the Drug Manufacturers - General sector in the LSE exchange.
Based on this 0Q1N:LSE may be fairly valued for its sector
The last closing price of 0Q1N:LSE's stock was USD 26.60.
The most recent market capitalization for 0Q1N:LSE is USD 244.23B.
Unfortunately we do not have enough analyst data on 0Q1N:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pfizer Inc.'s stock.
As per our most recent records Pfizer Inc. has 88,000 Employees.
Pfizer Inc.'s registered address is 66 Hudson Boulevard East, New York, NY, United States, 10001-2192.
You can get more information about it from Pfizer Inc.'s website at https://www.pfizer.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Frequently Asked Questions About Pfizer Inc. (0Q1N:LSE) Stock
Stock Target Advisor's fundamental analysis for Pfizer Inc.'s stock is Slightly Bearish.
0Q1N:LSE stock's dividend yield is 6.50%.
Our analysis grades 0Q1N:LSE stock's dividend yield at A+. This means that 0Q1N:LSE stock's dividend yield is above 100% of the stocks in the Drug Manufacturers - General sector in the LSE exchange.
Based on this 0Q1N:LSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 0Q1N:LSE's stock to indicate what its average analyst target is.
0Q1N:LSE stock's Price/Earning ratio is 0.68.
Our analysis grades 0Q1N:LSE stock's Price / Earning ratio at F. This means that 0Q1N:LSE stock's Price/Earning ratio is above 50% of the stocks in the Drug Manufacturers - General sector in the LSE exchange.
Based on this 0Q1N:LSE may be fairly valued for its sector
The last closing price of 0Q1N:LSE's stock was USD 26.60.
The most recent market capitalization for 0Q1N:LSE is USD 244.23B.
Unfortunately we do not have enough analyst data on 0Q1N:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pfizer Inc.'s stock.
As per our most recent records Pfizer Inc. has 88,000 Employees.
Pfizer Inc.'s registered address is 66 Hudson Boulevard East, New York, NY, United States, 10001-2192.
You can get more information about it from Pfizer Inc.'s website at https://www.pfizer.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0Q1N:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
